The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection

INTRODUCTION: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice. METHODS: A retrospective cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Stump, Trevor A., Nelson, Leigh Anne, Liu, Yifei, Kriz, Carrie R., Iuppa, Courtney A., Diefenderfer, Lauren A., Lang, Shelby E., Elliot, Ellie S. R., Sommi, Roger W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800326/
https://www.ncbi.nlm.nih.gov/pubmed/33505820
http://dx.doi.org/10.9740/mhc.2021.01.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800326/
https://www.ncbi.nlm.nih.gov/pubmed/33505820
http://dx.doi.org/10.9740/mhc.2021.01.012

Ejemplares similares